BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190918
DTEND;VALUE=DATE:20190920
DTSTAMP:20260515T010858
CREATED:20190613T103849Z
LAST-MODIFIED:20190613T111335Z
UID:21149-1568764800-1568937599@www.pharmajournalist.com
SUMMARY:7th Annual IMPACCT: RWE
DESCRIPTION:Returning for its 7th year\, IMPACCT: RWE provides top innovators and leaders in the real world evidence space with a comprehensive industry forum dedicated to supporting and advancing the generation and utilization of real world evidence across drug life cycle\, from clinical development to commercialization. \nJoin your peers and leading experts for a collaborative open discussion aiming to tackle key challenges to accelerate the meaningful implementation of real world evidence approaches to enhance clinical R&D outcomes\, drive patient-centricity\, and maximize the success of launch and commercialization activities. \nReal world evidence is at the root of an ongoing and critical transformation in medical care. By incorporating data from the real world into their development programs\, drug developers are now able to drive more patient-facing outcomes\, by supporting it with effective evidence-based decision-making across the product life cycle. \nAt a point of increasing maturity\, regulatory acceptance\, and growing innovation\, these are exciting times for all stakeholders actively involved in the efforts to advance the effective utilization and generation of real world evidence. \nLeading experts in the space will be tackling questions and sharing the latest case-studies around the use of RWE in: \n\nPatient identification\nClinical trial design\nHistoric control arms\nOutcomes research\nObservational research\nPost-launch safety studies\nDefining medical affairs strategy\nValue generation across the product life cycle\nRegulatory decision-making\nLabel extensions\nPatient access\n\n… and more. \nJoin them at this collaborative discussion platform that aims to bring together stakeholders from functions across clinical development\, HEOR\, regulatory and medical affairs\, epidemiology and RWE\, to overcome key challenges to define and implement a meaningful evidence generation plan that can effectively enhance clinical R&D\, support regulatory submission and decision-making\, and ultimately drive commercial success. \nTo learn more and to register online\, visit: https://impacct-rwe.com/
URL:https://www.pharmajournalist.com/event/7th-annual-impacct-rwe/
LOCATION:Aloft Boston Seaport District  401-403 D Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@impacct-rwe.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190918
DTEND;VALUE=DATE:20190920
DTSTAMP:20260515T010858
CREATED:20190613T104247Z
LAST-MODIFIED:20190613T105859Z
UID:21153-1568764800-1568937599@www.pharmajournalist.com
SUMMARY:2nd Annual AI-ML Clinical Development Summit
DESCRIPTION:Optimize When & How to Practically Apply AI & Machine Learning to Improve the Efficiency\, Patient Recruitment\, Design and Outcomes of Clinical Trials \nDesigned with leading AI and R&D experts from the likes of GSK\, Pfizer\, Takeda\, Celgene\, AbbVie and academic KOLs\, & containing real world use cases of AI in action\, this year’s AI-ML: Clinical Development Summit tackles both the critical scientific and technical challenges\, as well as identifying opportunities\, of implementing AI and machine learning (ML) to optimize your clinical development. \nThis is a critical time for drug developers to make more data-driven decisions that lead to improved efficacy\, safety and approval outcomes. Only here you will learn when\, strategically\, it is the right time to invest and apply AI to transform your clinical trial success. \nAs clinical failure rates remain unsustainable and the vast amounts of patient data increases further\, AI\, data and clinical development and pharmacovigilance experts from across large pharma and biotech are gathering to discover the growing practical applications of AI and ML. \nWith 60+ thought-leaders converging at the AI-ML Clinical Development Summit\, this will surely be an unrivalled opportunity for you to learn first-hand the growing practical applications of AI and ML. \n\nDiscover how to technically integrate and apply AI algorithms to enhance trial design\, improve patient selection and retention and achieve more precise pharmacovigilance studies.\nGrasp how AI will fundamentally change the paradigm of clinical trial execution and identify key areas where AI can positively impact your drug development decision making.\nHarness AI and extract maximum value to achieve regulatory success and accelerate novel therapeutic products to market.\n\nTo learn more and to register online\, visit: https://ai-clinicaldevelopment.com/
URL:https://www.pharmajournalist.com/event/2nd-annual-ai-ml-clinical-development-summit/
LOCATION:Aloft Boston Seaport District  401-403 D Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@ai-clinicaldevelopment.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190919
DTEND;VALUE=DATE:20190920
DTSTAMP:20260515T010858
CREATED:20190805T111428Z
LAST-MODIFIED:20190805T111428Z
UID:21848-1568851200-1568937599@www.pharmajournalist.com
SUMMARY:2nd Annual Pharma Packaging\, Labelling\, Serialisation\, Track and Trace 2019
DESCRIPTION:2nd Annual Pharma Packaging\, Labelling\, Serialisation\,\nTrack and Trace 2019\n“Securing your Supply Chain and Quality Management”\n19th September 2019\, Kohinoor Continental Hotel\, Mumbai\, India \n2nd Annual Pharma Packaging\, Labelling\, Serialisation\, Track and Trace 2019 overviews and integrates the business and technical problems that pharmaceutical companies should be aware of in order to fight the major global problem of counterfeit medicines. In addition to discussion of the problems\, this conference addresses serialisation; track and trace analytical techniques scientists use to detect counterfeits and identifying solutions to the threat of counterfeit medical products. Please contact me on KAVITHA at Email: kavitha@virtueinsight.co.in or Call: +91 9940791115. \nCONFERENCE DELEGATE REGISTRATION: \nIn order to register contact us on E-mail – kavitha@virtueinsight.co.in  Tel: +91 44 24762472 OR M: +91 9940791115 \nPlease note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite\, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer and entry won’t be granted at the event.  \n\nEarly Bird Discount Price (Valid until 06th August)  – 1 Delegate – (INR 10\,000 + GST (18%) per delegate) \nStandard Price (Valid From 07th August)  – 1 Delegate – (INR 15\,000 + GST (18%) per delegate) \nFor Bulk Booking of More Than 5 Delegates – Please let us know your interests.\n\nCONFERENCE SPONSORSHIP: \nE-mail – kavitha@virtueinsight.co.in  in Tel: +91 44 24762472 Or M: +91 9940791115 \nSponsor\, Exhibition Stall (Booth) and a paid Speaker Slots are also available. \nWe also have some sponsorship opportunities available for the event\, which gives you an opportunity to sponsor/speak/exhibit\, and create brand awareness. In addition\, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts. \n  \nIntroducing the First list of confirmed Speakers  \n\nK. BANGARURAJAN\, Joint Drugs Controller (INDIA)\, CDSCO (HQ)\nRUBINA BOSE\, Deputy Drugs Controller(India)\, CDSCO (WZ)\nMAYUR PARMAR  \, Deputy Collector\, Government Of Gujarat\nSUDHIR MOHAN BANSAL\, Vice President & India Head of Supply Chain Management\, Pfizer\nAMIT KALE\, Associate Vice President – Packaging and Automation\, Reliance\nOMPRAKASH S. SADHWANI\, Former Joint Commissioner and controlling Authority Food and Drug Administration (Maharashtra state)\nCHANDRA SEKHAR\, Vice President Quality\, Reliance Life Sciences\nUDAYKUMAR RAKIBE\, Founder\, PharmaMantra\nVAIBHAV KULKARNI\, Director – Regulatory Affairs\, Abbott Nutrition\nNARESH TONDARE\, Senior Director – National Regulatory Affairs\, Biocon\nSUNIL ACHARYA  \, Packaging Development\, S.C.P.L\nRITESH GOHEL\, Lead\, Global Serialisation and Track & Trace\, Sun Pharma\nS.R.SALUNKHE\, Former Assistant commissioner – FDA Maharashtra\nPRABIR DAS\, Head – Packaging Tech Services\, OSD\, Mylan Laboratories\nSANJAY KUMAR\, Head Of Legal\, Emcure Pharmaceuticals \nSANJAY DAVE\, CCO\, Anfarnd Consultancy Services\nVISHWAS SOVANI\, Founder Director\, Pharmawisdom\nGAURAJ SHAH\, Counsel\, Bombay High Court\nVIRENDRA SINGH\, Senior Manager\, Reliance Life Sciences\nJAGDISH VYAS\, Manager\, Abbott\nRAJSHRI CHETAN PARDESHI\, Manager – New Product & Commercial Packaging Development\, and Sourcing Head for Regulated Market\, Unosource Pharma (An Akums Enterprise)\nDARSHAN VARTAK \, Head Packaging Technical\, Anchor by Panasonic\n\nPlus many more \nWHO SHOULD ATTEND: \nCEO’s\, CTO’s\, CIO’s\, Presidents\, Vice Presidents\, Directors Heads & Managers of: \nPharmaceutical manufacturers and distributors\, Healthcare professionals\, Pharmacists\, Serialisation\, Track and Trace – Solution providers\, Brand – protection\, enforcement\, security\, integrity and management companies\, Drug regulatory agencies\, customs and police\, Intergovernmental organizations (IGOs) involved in healthcare and IPR protection\, Non-governmental organizations (NGOs) active in healthcare\, Patients’ representatives\, Healthcare research organizations\, Pharmaceutical associations\, Anti-counterfeiting organizations\, Packaging\, labeling and converting companies\, Authentication technology suppliers\, Anti-counterfeiting service suppliers – IP specialists\, investigators\, lawyers. \nGet more from the event\, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time\, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
URL:https://www.pharmajournalist.com/event/2nd-annual-pharma-packaging-labelling-serialisation-track-and-trace-2019/
LOCATION:Kohinoor Continental Hotel\, Mumbai\, India\, Mumbai\, India
ORGANIZER;CN="Virtue Insight":MAILTO:kavitha@virtueinsight.co.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190924
DTEND;VALUE=DATE:20190926
DTSTAMP:20260515T010858
CREATED:20180630T165012Z
LAST-MODIFIED:20190607T095126Z
UID:16582-1569283200-1569455999@www.pharmajournalist.com
SUMMARY:The Skin Microbiome Congress Westcoast
DESCRIPTION:The microbiome is set to be one of 2019’s biggest skincare trends\, therefore we are incredibly excited to bring The Skin Microbiome Congress back to San Francisco for the 6th event in our global series. \n \nLast year\, we connected 600+ industry leaders from pharma\, beauty and personal care multinational brands with innovative independent skincare brands\, bio-techs\, researchers and academics who are advancing the skincare industry. This year\, we continue to focus on developing a functional understanding of the skin microbiome\, keeping up with the latest scientific research and competitive intelligence\, as well as focusing on ‘the business of skin microbiome’ – commercializing the trend. \nWHAT MAKES 2019 DIFFERENT? \nNew topics including skin microbiome based-products\, skin conditions\, personalization\, skin-gut supplements\, anti-ageing and commercializing ethically marketed and clinically proven products; as well as presenting the latest academic research – more researchers than ever will be showcasing the latest developments from top universities. \nAlso new for 2019\, we are co-locating with our Microbiome Consumer Nutrition Congress – tailor your agenda and learn about the relationship of skin/gut microbiome and supplements. \nOur 2018 event SOLD OUT\, so make sure you don’t miss out! Download our agenda now. \nTo learn more about The Skin Microbiome Congress WestCoast\, and to register online\, visit https://go.kisacoresearch.com/l/678123/2019-05-30/5hp8 \nContact:\nPhone: +44 (0)203 897 6822\nEmail: mh@kisacoresearch.com
URL:https://www.pharmajournalist.com/event/skin-microbiome-congress-westcoast/
LOCATION:Hotel Kabuki\, 1625 Post St\, San Francisco\, CA\, 94115\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:mh@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190924
DTEND;VALUE=DATE:20190926
DTSTAMP:20260515T010858
CREATED:20190618T120255Z
LAST-MODIFIED:20190618T120255Z
UID:21237-1569283200-1569455999@www.pharmajournalist.com
SUMMARY:Microbiome Consumer Nutrition Congress
DESCRIPTION:The Human Microbiome is a hot bed for scientific innovation and represents a rapidly growing area of focus for nutritional companies. Rising consumer consciousness around personal healthcare and diet\, coupled with substantial improvements in R&D is fuelling a new wave of products that promote human gut health and wellbeing. The global probiotics market is expected to be worth $64 Bn by 2024\, an increase of $20bn from 2017. \nThe Microbiome Consumer Nutrition Congress connects the dots between business\, scientific innovation\, regulation and product development in the converging fields of functional foods\, pre/probiotics and the gut microbiome. \nTop 10 reasons to attend: \n\nConnect with and understand what leading nutrition\, consumer health and CPG companies look for when forming strategic partnerships.\nUnderstand the key branding and business features that VCs and Investors look for when investing in the next wave of gut health products\, and how to build an effective investment deck to support your company’s next round of fundraising.\nDiscover the key ingredients leading health and wellness retailers seek for the next best-selling pre/probiotic products.\nDiscover the latest advancements in personalized microbiome diagnostics and how these can be translated into nutrition programs and products.\nUnderstand the key business opportunities in the microbiome consumer nutrition space and how to capitalize on them.\nExpand your understanding of the modern health and wellness consumer\, the language they understand and what they’ll buy.\nApply the key take-aways from world leading microbiome consumer nutrition companies who have successfully branded and marketed their products and grown their businesses.\nDiscover the latest and most innovative scientific microbiome developments and how these can be utilized to develop the next generation of commercially successful consumer products.\nDevelop your understanding of regulatory considerations for microbiome-based products to improve the quality of your product’s claims and overcome regulation challenges.\nUnderstand the timing and cost realities of bringing a gut probiotic to market and utilize this knowledge to efficiently release your next product.
URL:https://www.pharmajournalist.com/event/microbiome-consumer-nutrition-congress/
LOCATION:Hotel Kabuki – 1625 Post St\, San Francisco\, California\, United States\, 94115
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190924
DTEND;VALUE=DATE:20190926
DTSTAMP:20260515T010858
CREATED:20190703T094347Z
LAST-MODIFIED:20190703T094347Z
UID:21427-1569283200-1569455999@www.pharmajournalist.com
SUMMARY:Asia Skin Microbiome 2.0 Congress
DESCRIPTION:This 2-day congress includes both scientific and commercial interests with topics ranging from host-microbe interaction\, skin disease\, emerging technologies\, interventional and cosmetic advancements\, and regulatory considerations. It features new and exciting case studies\, presentations and expert-led panel discussions and an exhibition of solution providers showcasing products\, and ample networking opportunities. \nSpecific focus areas include: \n\nSkin health\, wellbeing\, and microbiome-associated skin disease\nSkin immunology / Microbe-host interaction\nMicrobe-based therapies\nEmerging technologies for skin microbiome research and innovation\nCosmetic vs Therapeutic regulatory considerations\nCase studies / Academic-Commercial partnerships\n\n10% OFF – code : sk/smca/10 expire on 26th Aug 2019. Contact :  saffuan@global-engage.com for group booking
URL:https://www.pharmajournalist.com/event/asia-skin-microbiome-2-0-congress/
LOCATION:Singapore – Hotel Fort Canning
ORGANIZER;CN="Global Engage":MAILTO:saffuan@global-engage.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190925
DTEND;VALUE=DATE:20190927
DTSTAMP:20260515T010858
CREATED:20190402T114527Z
LAST-MODIFIED:20190402T114527Z
UID:20170-1569369600-1569542399@www.pharmajournalist.com
SUMMARY:Biobanking 2019
DESCRIPTION:With the estimated revenues of the global biobanking industry reaching US$ 27.54 billion in 2020\, backed by an explosive CAGR of 9.5% between now and 2026. This market growth is fuelled by the increasing drive towards precision and personalised medicine and thus\, quality biosamples are now in soaring demand. \n \nCome join us in September 2019 and; thoroughly understand the latest developments in the biobanking industry; network with the industry experts and key opinion leaders; gain insight into how the biobanking industry at the forefront at driving precision medicine and enhancing research and discover ‘Drone4Care’\, how drone delivery of biosamples can be a reality. \nThe event will bring together internationally recognised biorepositories\, scientific pioneers from pharmaceutical companies\, and academics to strengthen current knowledge in biosample management and their research applications. We will cover the most relevant hot topics including: the latest biorepository technological breakthroughs\, the best practices in biobanking\, shifts in the biosample regulation landscape\, the international biobank societies with ESBB and ISBER\, along with a whole host of successful biobanking business model structures to help reinvigorate your biobank.  \nBenefits of attending: \n\nDiscover ‘Drone4care’ from Laurent Dollé\, the innovative and daring plan to use drones for the delivery of biomaterial. Additionally\, he will be detailing the new promising technology of Tissue Microarray\, a bioprocessing technology that can reduced the number of needed biosamples for research from 200 down to 1\n\n\nHear from UK Biobank on the continual impact of GDPR on the biobanking landscape\n\n\nLearn about a diverse range of the most successful biobanking business models from real case studies\n\n\nGain insight from the global biobank collaboration societies of ESBB and ISBER\, see how you can place your biobank on the international stage\n\nView the full agenda online: \nEarly bird rates: \n\nBOOK BY 30TH APRIL AND SAVE £400\nBOOK BY 31ST MAY AND SAVE £300\nBOOK BY THE 28TH JUNE AND SAVE £200\n\nPlus\, two interactive half day pre-conference workshops: \nWorkshop A: Enhance your biobank’s commercial prowess through the application of financial and economic tools along with how to improve your biosamples data quality\nWorkshop Leader: Laurent Dollé\, Managing Director\, BWB (Biothèque Wallonie Bruxelles)\n8.30 – 12.30 \nWorkshop B: The Organic Development of a Sustainable Academic Biobank\nWorkshop Leader: Mary-Beth Joshi\, Director\, Biobank & translational Research Core\, Duke University Medical Centre\n1.30 – 5.30 \nFollow us:  @SMiPharm #smibiobanking \nTo learn more and to register online\, visit www.biobanking-event.com/Pharmajwl
URL:https://www.pharmajournalist.com/event/biobanking-2019/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Limited":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190925
DTEND;VALUE=DATE:20190927
DTSTAMP:20260515T010858
CREATED:20190404T105139Z
LAST-MODIFIED:20190404T105139Z
UID:20198-1569369600-1569542399@www.pharmajournalist.com
SUMMARY:SMi’s 10th Annual Biosimilars Conference
DESCRIPTION:Conference:  Wednesday 25 and Thursday 26 September 2019\nWorkshop: Tuesday 24th September 2019 \nChaired by Michel Mikhail\, International Expert Regulatory Affairs\, Global Expert Biosimilars \nDiscussing future regulatory\, commercial and legal challenges of biosimilars \nSMi Group are delighted to announce the 10th annual Biosimilars Conference taking place on 25th and 26th September 2019. This year’s event will be our first global event taking place in London\, UK. The event’s focus is to highlight the current challenges in the biosimilars market and discuss current undergoing plans or developments to overcome these challenges. \nThe biosimilars market is forecasted to reach USD$23.6B by 2023 at a compound annual growth rate (CAGR) of 31.70%. Factors driving the increase of this market include growing demand for biosimilar drugs due to their cost-effectiveness\, growing incidence of chronic diseases\, and strategic collaborations resulting in enhanced productivity and clinical trial activities. \nWith the expiry dates of major patents fast approaching\, the emerging gap in the market for biosimilars is now a major attraction for manufacturers. As the availability of biosimilars could potentially reduce direct spending by USD$54B by 2026\, the question is what can current biosimilar producing companies do to join this market to benefit the patients\, physicians and investors? \n BENEFITS OF ATTENDING \n\nHEAR about current strategies under development to overcome challenges with patents currently faced by many biosimilar developers\nDISCUSS the possible changes in regulatory approval of biosimilars in the UK post Brexit\, and how this will impact market entry\nEXPLORE the latest methods in use to maintain the relationship between stakeholders\, doctors and patients\, with the influence of governing bodies\nREVIEW FDA regulations for the approval of Biosimilars and the latest approvals\n\nPLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS\nTuesday 24th September 2019\, Copthorne Tara Hotel\, Central London\, UK \nA: US-FDA Interchangeability Guideline\n08.30 – 12.30\nWorkshop Leader: Michel Mikhail\, International Expert Regulatory Affairs\, Global Expert of Biosimilars \nB: Global Development of Biosimilars – what can the US learn from Europe’s Strategies to promote biosimilar uptake\n13:30 – 17:30\nWorkshop Leader: Rodeina Challand\, General Manager\, Challand Biosimilar Consulting \nWHO SHOULD ATTEND? \nPresidents\, Vice Presidents\, Managing Directors\, Directors\, Associate Directors\, Chiefs\, Heads\, Principals\, Managers and Analysts of: \n\nBiosimilar Development\nProduct Development\nCommercialization\nMarket Access\nMedical Affairs\nIntellectual Property\nBioloigcs\nBiopharmaceuticals\nResearch and Development\nGenerics\nBiobetters\nBusiness Development\nStrategic Marketing\nDrug Development\nClinical Trials\nImmunogenicity Studies\n\nGlobal Presence: Attendees from all over the world attend our events. Gain hands on insight from representatives from UK\, Europe and USA. \nEARLY BIRD-RATES \n\nBOOK BY 30TH APRIL AND SAVE £400\nBOOK BY 31ST MAY AND SAVE £300\nBOOK BY 28TH JUNE AND SAVE £200
URL:https://www.pharmajournalist.com/event/smis-10th-annual-biosimilars-conference/
LOCATION:Copthorne Tara Hotel\, London\, UK\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191002
DTEND;VALUE=DATE:20191004
DTSTAMP:20260515T010858
CREATED:20190606T122433Z
LAST-MODIFIED:20190606T123252Z
UID:21055-1569974400-1570147199@www.pharmajournalist.com
SUMMARY:The Marketing Disruption Summit USA
DESCRIPTION:Harness data & tech to engage customers and dominate markets  \nAs consumer attitudes shift to “one-click” pharma needs to shift with it. \nImproving customer engagement strategies and processes are the key to improving reputations and delivering value. But how do we get there? \nThe answer\, we can’t do it alone. The responsibility to deliver an excellent customer engagement strategy sits across several functions\, at eyeforpharma Marketing Disruption Summit USA we’ll be going beyond the theoretical and bringing together all stakeholders to deliver a blueprint to revitalize customer relationships. \n2019 Expert speakers include: \n\nAnish Shindore\, Head of Digital Acceleration\, Sanofi\nMartina Flammer\, SVP\, Customer Value\, Boehringer Ingelheim\nJudith Lyster\, Digital/IT Leader Canada\, Eli Lilly & Co.\nMatt Smith\, Global Lead\, Strategy\, Digital & Operations\, Pfizer\nChad Dau\, Head of Business and Market Analytics\, Astellas\nRamon Vega\, Director\, Global Pharma Marketing IT\, Merck\n\nOver 200 attendees from across both front-end and back-end: Marketers\, IT/technology\, transformation agents\, Data\, Field Operations and more…will discuss how to unify efforts and develop strategy and process that performs in the field. \nWith the latest case studies from Sanofi\, Pfizer and Ouchie\, panels led by pharma leaders and out of industry expert sessions that will help you create the ultimate\, effortless customer engagement strategy– this is the event to ensure your business is ready to dominate the market.
URL:https://www.pharmajournalist.com/event/the-marketing-disruption-summit-usa/
LOCATION:Sheraton Philadelphia Society Hill Hotel
ORGANIZER;CN="eyeforpharma":MAILTO:sburbach@eyeforpharma.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191008
DTEND;VALUE=DATE:20191011
DTSTAMP:20260515T010858
CREATED:20190703T092011Z
LAST-MODIFIED:20190703T092011Z
UID:21420-1570492800-1570751999@www.pharmajournalist.com
SUMMARY:19th Pharmacovigilance 2019
DESCRIPTION:19th Pharmacovigilance 2019 \n“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance\, drug safety and risk management” \n08th – 10th October 2019\, Hotel TBC\, Cambridge\, Boston\, USA \n19th Pharmacovigilance 2019 will bring together top pharmaceutical\, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.  The entire program will cover the detection\, analysis and prevention of adverse drug reactions.  It will be studied with the help of case studies and industry experiences.  Hence\, this conference will provide an important platform for pharmacovigilance stakeholders to discuss and share best practices in expediting Pv development. \nSPONSORS: \n\nGOLD SPONSOR: Brookwood\, AB Cube\, AWINSA Life Sciences \nBRONZE SPONSOR: 4C Pharma Solutions\n\nKEY SPEAKERS: \n\nDEREK ROY\, Resident Agent in Charge\, FDA\nBRUNO MENDEZ\, VP Global Quality Head Pharmacovigilance\, Sanofi\nMARIETTE BOERSTOEL-STREEFLAND\,  VP PharmacoVigilance & Drug Safety\, Alexion Pharmaceuticals\nTEGINDER SINGH\, Senior Director Global Regulatory Affairs\, Johnson & Johnson\nCOLLEEN WALSH\, Senior Director\, Pharmacovigilance & Regulatory Quality Management Operations\, Alexion Pharmaceuticals\nGERSON PELTZ\, Senior Director – Oncology Safety Risk Lead\, Pfizer\nBRUCE DONZANTI\, Senior Group Director\, Regulatory Pharmacovigilance Policy\, Genentech\nWILLIAM WANG\, Executive Director\, Clinical Safety Statistics\, Merck\nMELVIN MUNSAKA\, Senior Director\, Head Safety Statistics\, Abbvie\nXIAO NI\, Director\, Scientific Computing and Consulting\, Novartis\nSHARON REID\, Director\, Risk Management Product Lead\, Pfizer\nHARISHA KADALI\, Associate Medical Director\, Takeda Pharmaceuticals\nJAYLAXMI NALAWADE\, Associate Director – Pharmacovigilance and REMS\, Lupin\nRICHARD WOLF\, Executive Director\, Pv Operations\, CSL Behring\nPHIL TREGUNNO\, Group Manager – Vigilance\, Intelligence and Research Group\, MHRA (UK)\nTOYIN ADEWOLE\, Associate Director\, Drug Safety – Clinical Research\, Supernus Pharmaceuticals\nSHEETAL KHEDAR\, Senior Director\, Regulatory Science\, Sarah Cannon Development Innovations\nDAVID HUTCHINSON\, Founder\, Brookwood International Academy\nMELVA COVINGTON\, Senior Principal\, AGAPE Strategic Solutions\nBEN LOCWIN\, Senior Vice President\, Quality\, Lumicell\n\nWHO SHOULD ATTEND: \nCEO’s\, CTO’s\, CIO’s\, Presidents\, VPs\, Directors\, Heads\, Managers\, Scientific Advisors\, Consultants of: \nPharmacovigilance\, Pharmacoepidemiology\, Pharmacogenomics\, Drug/Product Safety\, Drug Development\, Information and Clinical Data Management\, Clinical Pharmacology\, Clinical Safety\, Periodical safety update Reports\, Risk Management\, Research & Development\, Quality Assurance\, Patient Safety\, Signal Detection\, Safety Surveillance\, Outcomes Research\, Data Analysis\, Epidemiology\, Medical Affairs\, Regulatory Affairs and Compliance\, Information technology\, Sales and Marketing \nCONFERENCE SPONSORSHIP: \n E-mail – kavitha@virtueinsight.co.in  or Tel: +44 2036120886 \n Sponsor\, Exhibition Stall (Booth) and a paid Speaker Slots are also available. \nWe also have some sponsorship opportunities available for the event\, which gives you an opportunity to sponsor/speak/exhibit\, and create brand awareness. In addition\, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts. \nCONFERENCE REGISTERATION: \nIn order to register contact us on Email: kavitha@virtueinsight.co.in  Tel: +44 2036120886 \nConference Only: \n\nIntroductory Offer (3 delegate places for the price of 2) A huge saving (Limited seats left)\nEarly Discount (25th June 2019 – 19th August 2019): (£1299 per delegate)\nStandard Registration (20th August 2019 Onwards): (£1499 per delegate)\n\nConference + Workshop: \n\nIntroductory Offer (3 delegate places for the price of 2) A huge saving – (Limited seats left)\nEarly Discount (25th June 2019 – 19th August 201): (£1499 per delegate)\nStandard Registration (20th August 2019 Onwards): (£1699 per delegate)\n\nWorkshop Oniy – £399 \nWhether you are on the branded or generic side\, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway.  Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry\, research and development costs\, and regulatory hurdles\, which are balanced against an enormous potential for increased profit margins. Expand your knowledge of the latest business models and strategies in the high-level conference.
URL:https://www.pharmajournalist.com/event/19th-pharmacovigilance-2019/
LOCATION:Double Tree Suites by Hilton Hotel – 400 Soldiers Field Road\, Boston\, MA 02134
ORGANIZER;CN="Virtue Insight":MAILTO:kavitha@virtueinsight.co.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191008
DTEND;VALUE=DATE:20191010
DTSTAMP:20260515T010858
CREATED:20190729T102418Z
LAST-MODIFIED:20190729T115346Z
UID:21733-1570492800-1570665599@www.pharmajournalist.com
SUMMARY:Blockchain for Health Supply Chain
DESCRIPTION:Blockchain for Health Supply Chain: Real-World Application is the definitive event for all key stakeholders across the supply chain to forge a path for collaboration and adoption of this transformative technology. Consortium and tech-agnostic\, this conference provides a neutral platform for cross-community sharing of PoCs and discussion about the common challenges facing all blockchain implementation projects. \n \nIn its 2nd year\, this event will continue to tackle the deep and difficult challenges associated with blockchain implementation – providing essential guidance for active adopters as well as those preparing to embark on their blockchain journey. Our mission is to help you get beyond PoC – and to get blockchain out of the lab and into business. \nFind out more – get free event brochure here:  https://ter.li/p0t4xu \nContact\n(+1) 617 455 4188\ninfo@hansonwade.com
URL:https://www.pharmajournalist.com/event/blockchain-for-health-supply-chain/
LOCATION:The Westin Boston Waterfront\, 425 Summer St\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191009
DTEND;VALUE=DATE:20191011
DTSTAMP:20260515T010858
CREATED:20190513T090618Z
LAST-MODIFIED:20190513T090618Z
UID:20692-1570579200-1570751999@www.pharmajournalist.com
SUMMARY:4th European Prefilled Syringes Summit
DESCRIPTION:After the three successful ACI’s European Prefilled Syringes Summit\, we are pleased to inform you that the 4th edition will take place this month on the 9th & 10th October in Berlin\, Germany. \n \nThe two day event will explore the advancements in regulatory guidelines including Article 117 and what this will mean for interactions with notified bodies. The conference will highlight technical advancements in product design and usage\, looking at the move towards autoinjectors. Our expert speakers will compare the use of glass syringes with plastic syringes\, focus on how to minimise the impact of extractables and leachables\, and address CCI regulations. Through in-depth presentations and interactive panel discussions\, the conference will shed light onto how the industry is responding to disruptive technology\, connectivity\, speed to market\, and next generation syringes. \nKey Topics Include: \n\nMedical Device Regulations overview and updates\nTechnical advancements in product design and usage\nSuitability of primary packaging components\nExtractables and leachables\nManufacturing and supply barriers\nImproving adherence through device innovation and human factors\nCreating value with connectivity\nDevelopments in biologics\nShifting to a pay-per-outcome market\n\nFor more information & 15% subscribers discounted registration\, contact Mohammad Ahsan on +44 (0) 203 141 0606 or email: mahsan@acieu.net   \nJoin us in Berlin to exchange your point of view with your peers and engage in excellent networking opportunities.
URL:https://www.pharmajournalist.com/event/4th-european-prefilled-syringes-summit/
LOCATION:Berlin\, Germany
ORGANIZER;CN="Active Communications Europe Ltd (ACI)":MAILTO:mahsan@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191009
DTEND;VALUE=DATE:20191011
DTSTAMP:20260515T010858
CREATED:20190517T135859Z
LAST-MODIFIED:20190814T090558Z
UID:20796-1570579200-1570751999@www.pharmajournalist.com
SUMMARY:Pharmaceutical Cleanroom Technology Europe Conference
DESCRIPTION:SMi’s Pharmaceutical Cleanroom Technology Europe Conference\nConference: Wednesday 9 and Thursday 10 October 2019\nWorkshop: Tuesday 8 October 2019\nLocation: Copthorne Tara Hotel\, London\, UK\nwww.cleanroomtechnology.co.uk/pjwl  \nSponsored by: Contec and Dupont  \nCHAIRMAN: James Drinkwater\, Chairman\, Pharmaceutical & Healthcare Science Society  \nAddressing the Microbiological Aspects in Cleanroom Design and Engineering \nSMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom Technology Europe Conference\, taking place on the 9th and 10th October 2019 in London\, UK. As the first event in Europe that focuses on cleanroom technology in the pharmaceutical industry\, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point. \n \nThis one-of-a-kind meeting will facilitate networking opportunities with key opinion leaders from all areas of pharmaceuticals\, biologicals\, and cleanroom industry experts to explore hot topics within cleanroom design and engineering\, best practices and regulation\, environmental and contamination control\, and pharmaceutical microbiology. \nIn 2025\, the global cleanroom technology market is expected to reach nearly $5 billion. Stringent regulatory standards for product approvals\, technological advancements in cleanrooms\, initiatives taken by private organisations to create awareness regarding cleanroom and growth of the healthcare sector globally are among the few factors expected to drive the market. \nCompliance with the standards for product approvals is crucial and as a result manufacturing companies in various industries are dependent on cleanroom technology.  \nBENEFITS OF ATTENDING \n\nEXPLORE the characteristics and relevance of air flow to better advise cleanroom design\, engineering and manage contamination\nDISCUSS the most current approaches to minimised cost and improved energy efficiency without compromising product quality\nEXAMINE the latest contamination control strategies from leaders in the pharmaceutical industry\nGAIN insight into cleaning and disinfection protocols from a risk-management approach\n\n PLUS AN INTERACTIVE HALF DAY PRE-CONFERENCE WORKSHOP \nTuesday 8th October 2019\, Copthorne Tara Hotel\, London\, UK \nEnvironmental Classification\, Qualification and Monitoring of GMP Controlled areas referencing ISO 14644-1 and risk based GMP \nWorkshop Leader: James Drinkwater\, Chairman\, Pharmaceutical and Healthcare Science Society \nWHO SHOULD ATTEND? \nSenior Micro Manager\, QC Manager\, Quality Director\, Clean Room Design Managers\, Design\, Qualify and Testing – Clean Room (across the board)\, Head of Clean Room Technologies\, Head of Compounding Pharmacies\, Head of Clinical Drug Products\, Head of Clinical Medical Device \nGlobal Presence: Attendees from all over the world attend our events. Gain hands on insight from representatives from UK\, Europe and USA. \nEARLY BIRD-RATES \n\nBOOK BY 31ST MAY AND SAVE £400\nBOOK BY 28TH JUNE AND SAVE £300\nBOOK BY 30th AUGUST AND SAVE £200
URL:https://www.pharmajournalist.com/event/pharmaceutical-cleanroom-technology-europe/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T010858
CREATED:20190124T074007Z
LAST-MODIFIED:20190124T074007Z
UID:19196-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:Novel Antibody Therapeutics Congress
DESCRIPTION:The Novel Antibody Therapeutics Congress one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/novel-antibody-therapeutics-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T010858
CREATED:20190124T074341Z
LAST-MODIFIED:20190124T074341Z
UID:19201-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:Adoptive Cell Transfer Congress
DESCRIPTION:The Adoptive Cell Transfer Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/adoptive-cell-transfer-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T010858
CREATED:20190124T074554Z
LAST-MODIFIED:20190124T074554Z
UID:19206-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:TMB & Neoantigen Congress
DESCRIPTION:The TMB & Neoantigen Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/tmb-neoantigen-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T010858
CREATED:20190124T074802Z
LAST-MODIFIED:20190124T074802Z
UID:19211-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:Liquid Biopsies Congress
DESCRIPTION:The Liquid Biopsies Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/liquid-biopsies-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191010
DTEND;VALUE=DATE:20191012
DTSTAMP:20260515T010858
CREATED:20190124T075036Z
LAST-MODIFIED:20190124T075036Z
UID:19216-1570665600-1570838399@www.pharmajournalist.com
SUMMARY:Flow Cytometry Congress
DESCRIPTION:The Flow Cytometry is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts\, researchers\, investors and businesses.
URL:https://www.pharmajournalist.com/event/flow-cytometry-congress/
LOCATION:London\, United Kingdom – Venue to be confirmed
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191015
DTEND;VALUE=DATE:20191017
DTSTAMP:20260515T010858
CREATED:20190509T101547Z
LAST-MODIFIED:20190509T110535Z
UID:20621-1571097600-1571270399@www.pharmajournalist.com
SUMMARY:SMi’s 9th Annual Orphan Drugs & Rare Diseases Conference
DESCRIPTION:SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference\, taking place on the 15th and 16th October 2019 in London\, UK. \n \nThe orphan drug market is continuously growing and is expected to reach $176 billion by 2020\, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020\, orphan drugs are set to account for 19% of global prescription sales. \nThis is due to the arising interest for pharmaceutical companies\, primarily for the underlying benefits\, including the potential discovery of mechanisms for more common diseases\, and the involvement of many smaller biotechnology start-up companies who are more focused on rare diseases. \nThe 2019 agenda features various key presentations by leading solution providers\, biotechnology companies\, clinical researchers\, regulatory professionals and charity leaders discussing possible ways to accelerative orphan drug development and access to rare disease patients\, including the introduction of recent technologies and products to help aid the access of orphan drugs. \nBENEFITS OF ATTENDING \n\nHEAR about the success of orphan drug launches following the heavy involvement of patient advocacy programs\nDISCUSS the potential changes in assessing the development of medicines across Europe\nEXPLORE the future landscape orphan drugs following the market access and reimbursement challenges providers are currently facing.\n\nPLUS AN INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOP\nThursday 17th October 2019\nA deep dive into strategies for accelerating patient access of orphan drugs\nWorkshop Leader: Workshop Leaders: Solange Corriol-Rohou\, Senior Director Regulatory Affairs & Policy Europe\, AstraZeneca\nCecile Ollivier\, Chief Operating Officer\, Aparito \nWHO SHOULD ATTEND? \nCEOs\, CSOs\, Vice Presidents\, Directors\, Heads\, Principals working in: \n\nMedical Affairs\nMedical Advisory\nClinical Operations\nRare Disease Research\nPatient Advocacy\nCommercial Officer\nOrphan Drug Therapeutics\nHealthcare\nRegulatory Affairs\nRare Disease Charity Officers\n\nFor more details and to register or this event\, visit the website at http://www.orphandrugs.co.uk/PJWL \nEARLY BIRD-RATES  \n\nBOOK BY 31ST MAY AND SAVE £400\nBOOK BY 28TH JUNE AND SAVE £300\nBOOK BY 30TH AUGUST AND SAVE £200
URL:https://www.pharmajournalist.com/event/orphan-drugs-rare-diseases-conference/
LOCATION:Holiday Inn Kesington Forum\, London\, UK\, London\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191015
DTEND;VALUE=DATE:20191017
DTSTAMP:20260515T010858
CREATED:20190625T112416Z
LAST-MODIFIED:20190625T112709Z
UID:21320-1571097600-1571270399@www.pharmajournalist.com
SUMMARY:Marketing and Customer Innovation Europe
DESCRIPTION:We’re at a crossroads. On the one hand\, pharma marketeers must adopt and master an array of technological innovations to transform customer relationships and better meet rising expectations. \nOn the other\, successful innovation is currently inhibited by our failure to master the basics – with inconsistent multichannel interaction and a low cultural acceptance of non-traditional methods\, whether it’s digital or education-led initiatives. \nLet’s build the capability to create new collaborations and partnerships\, both internally and externally\, to strengthen what’s possible yet at the same time deliver on the fundamentals of customer-value. It’s no longer a nice-to-have – we must do this or face rapid extinction.  \neyeforpharma Marketing and Customer Innovation Europe will bring together 250+ Marketing\, Digital\, CX\, IT/CRM and Business Partnership/Technology pharma executives to bridge internal divides\, share the industry pushing case studies and build market-leading customer experiences. \nAttend and gain unique insights on: \n\n          Collaborate or die.\nBreak internal silos in commercial and medical affairs\, partner with healthcare’s key innovators and decision makers\, and bring the brightest FMCG knowledge and leadership inside\n          You’re brand obsessed!\nCreate true customer partnerships and influence behaviours with an above-brand\, education-led approach\n          Digital transformation needs a cultural revolution.\nDemonstrate the value of digital initiatives to ensure adoption across affiliates and departments\n          Harness big data.\nPersonalise customer interactions with an internal infrastructure built to comprehend and connect insights\n          Achieve customer-centricity.\nEnsure new channel innovations and digital investments remain purpose-led to meet customer needs\n          Real-life technological innovation.\nChannel your investments and cut through unnecessary hyperbole with current applications of technology breakthroughs\n\n4 Reasons to Attend: \nCase Studies: Practical\, tangible advice and actions from your peers which you can put into practise in your own company \nOut of Industry Speakers: Hear from some of the biggest leader in marketing out of the pharma industry sharing their top tips \nTeam Benefits: Group rates are now available for 2+ attendees\, to ensure all interested peers can take advantage of this learning opportunity \nAll Stakeholders in One Room: Working together to ensure we are engaging in solution focused exchanges across all departments \nBook before 19th July to save €300
URL:https://www.pharmajournalist.com/event/marketing-and-customer-innovation-europe/
LOCATION:Novotel West London One Shortlands\, London\, W6 8DR\, United Kingdom
ORGANIZER;CN="eyeforpharma":MAILTO:mmayhew@eyeforpharma.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191016
DTEND;VALUE=DATE:20191018
DTSTAMP:20260515T010858
CREATED:20190625T090134Z
LAST-MODIFIED:20190625T090134Z
UID:21316-1571184000-1571356799@www.pharmajournalist.com
SUMMARY:LogiMed 2019
DESCRIPTION:LogiMed is the only European event designed for medical device supply chain directors and their teams. It is where Heads of Supply Chain and Logistics from the top pharma companies in Europe gather to benchmark\, interact\, network and develop professionally. \nOnly at LogiMed will you have the chance to learn from and network with all the major medical device companies\, key hospitals\, and the most innovative industry suppliers. All openly sharing the do’s and don’ts to help you adapt to new regulations\, redefine your supply chain strategy-covering planning\, logistics and customer service to achieve greater end-to-end supply chain operations. \nDownload the agenda to find out exactly who is speaking\, what the hottest topics are and how LogiMed can benefit you. LogiMed 2019 will bring together 250 Medical Device Supply Chain Professionals and 50 expert speakers over 2 value packed days. \nMixing interactive presentations from Global Heads of Supply Chain with practical\, interactive ‘how to’ case studies from proven procurement experts; LogiMed helps Medical Device Manufacturers to transform their supply chain. \nAs a proud Media partner of the event\, we are pleased to offer you an exclusive 15% discount off the full price to attend\, using our code: PHARMAJOUR19 \nBook your place online here: https://bit.ly/2J5viSu
URL:https://www.pharmajournalist.com/event/logimed-2019/
LOCATION:ROTTERDAM – NHOW HOTEL
ORGANIZER;CN="Worldwide Business Research":MAILTO:logimed@wbr.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191021
DTEND;VALUE=DATE:20191023
DTSTAMP:20260515T010858
CREATED:20190514T110507Z
LAST-MODIFIED:20190514T110507Z
UID:20716-1571616000-1571788799@www.pharmajournalist.com
SUMMARY:Highly Potent Active Pharmaceutical Ingredients USA (HPAPI) Conference
DESCRIPTION:SMi is delighted to announce its USA Highly Potent Active Pharmaceutical Ingredients conference coming to Boston on the 21th – 22th October 2019. \nThe inaugural HPAPI USA conference will explore how current technologies are streamlining the HPAPI industry with artificial intelligence and machine learning\, to improve risk assessment and validation. The latest emerging therapies will be discussed including bispecific antibodies\, oncolytic viral complexes and hormones. Will the super-high level 5 banding for these biologics prove effective or inept? Are current containment planning and solutions truly ensuing the health of workers? These questions will be answered along with unique insights including HPAPI manufacturing technologies. \nAttend the conference and join our networking platform with industry professionals to provide you with the expertise to overcome challenges. \nDISCUSSION HIGHLIGHTS: \nOncology Antibody-Drug Conjugates (ADC)\, the ongoing developments and the containment challenges imposed \nHow to correctly assess\, plan and implement the most cost-effective containment \nEmerging HPAPI therapies\, oncolytic viruses their potential and challenges \nAlternative HPAPI manufacturing technologies to reduce powder exposure and improving safety along with enabling continuous manufacturing \nThe reality of oncology ADC and HPAPI: are most drugs using ‘highly-potent’ to improve brand image? Has 50 years of ADC R&D for oncology with no cure shows signs of no promise? \nView the full agenda: www.hpapi-usa.com/PJwl
URL:https://www.pharmajournalist.com/event/highly-potent-active-pharmaceutical-ingredients-usa-hpapi-conference/
LOCATION:Sheraton Boston Hotel\, Boston USA\, United States
ORGANIZER;CN="SMi Group Limited":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191022
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T010858
CREATED:20190806T094720Z
LAST-MODIFIED:20190806T094807Z
UID:21857-1571702400-1571961599@www.pharmajournalist.com
SUMMARY:Lab Asset & Facility Management In Pharma 2019
DESCRIPTION:The 2nd annual Lab Asset & Facility Management in Pharma summit is the only industry-led platform to join 120+ senior experts from Lab Operations\, Facility Management\, Lab Supplies and Procurement across pharma\, biotech\, CROs and research institutions. \n \nJoin your colleagues who are beginning to implement end-to-end asset management programs to optimize spend and gain better visibility of inventory and equipment lifecycles in order to maximize capital efficiency. \nAt the event\, you’ll delve into your core challenges\, including: \n\nHow to increase R&D productivity and avoid unnecessary downtime\nRevise the operating model for lab facility and asset supplies\nOptimize utilization of lab equipment and facility footprint\nExplore new technologies and IoT for asset monitoring and predictive maintenance\nExtend and manage your equipment lifecycle\nEvaluate your relationships and collaborations with OEMs\n\nDon’t miss out on this one of a kind meeting to engage with your peers and re-define best practice for tomorrow’s operations! \nTo learn more and to register online\, visit: https://ter.li/lafm-listing-home
URL:https://www.pharmajournalist.com/event/lab-asset-facility-management-in-pharma-2019/
LOCATION:The Westin San Diego\, 400 West Broadway\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191022
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T010858
CREATED:20190924T120933Z
LAST-MODIFIED:20190924T120933Z
UID:22557-1571702400-1571961599@www.pharmajournalist.com
SUMMARY:2nd Targeted Protein Degradation Summit
DESCRIPTION:Finally Drug the “Undruggable” Through Targeted Protein Degradation.  Encapsulating the excitement of the field of protein degradation; The 2nd TPD Summit 2019 is the definitive\, comprehensive and industry-dedicated conference for the field of protein degradation – focused on optimizing target validation\, improving medicinal chemistry & rational design and ultimately accelerating the translation of selective\, bioavailable and effective protein degraders into clinical trials. \nWith 50+ speakers\, 40+ late-breaking case studies\, 3 dedicated streams\, 6 technical deep-dives & 400+ attendees\, TPD 2019 is the most comprehensive and the definitive guide for large pharma\, innovative biotech and leading academic researchers to capitalize on this emerging therapeutic class and make targeted protein degradation a blockbuster therapeutic approach that improves patient outcomes. \nAs the previously untapped drug discovery opportunity promised within the proteome becomes a reality and “undruggable” targets are finally being reached\, the field of targeted protein degradation is truly changing the face of small molecule drug discovery. In the pursuit to demonstrate safe and effective clinical results\, it’s clear that a set of unique development challenges must be overcome for these novel therapeutics to achieve their seemingly limitless potential. \nView the program and speaker list here: https://ter.li/idctdn
URL:https://www.pharmajournalist.com/event/2nd-targeted-protein-degradation-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Drive\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T010858
CREATED:20170510T082131Z
LAST-MODIFIED:20190514T085314Z
UID:1755-1571788800-1571961599@www.pharmajournalist.com
SUMMARY:SAPHEX 2019
DESCRIPTION:SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre\, Johannesburg\, South Africa. \n \nSAPHEX serves a primary platform for both local and international companies working in the South African or Africa pharmaceutical manufacturing industry. The exhibition brings together key visiting pharma suppliers and buyers\, with a range of exhibitors from across the pharmaceutical sector. \nDon’t miss out on your chance to participate at this event. \nTo learn more about this event and to register online\, visit www.saphex.co.za \n 
URL:https://www.pharmajournalist.com/event/saphex/
LOCATION:GALLAGHER CONVENTION CENTRE\, 10 RICHARDS DRIVE\, HALFWAY HOUSE\, MIDRAND\, 1685\, South Africa
ORGANIZER;CN="SAPHEX":MAILTO:jessica@saphex.co.za
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T010858
CREATED:20180620T145021Z
LAST-MODIFIED:20190521T094434Z
UID:16375-1571788800-1571961599@www.pharmajournalist.com
SUMMARY:Lyophilization USA
DESCRIPTION:SMi Presents the 5th annual\nLyophilization USA Conference\nDate: October 23-24\, 2019\nWorkshop: October 25\, 2019\nLocation: Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, USA\nWebsite: www.lyophilisation-usa.com/PJBan \nAbout Lyophilization USA \nThe SMi Group is pleased to invite you to the 5th Annual Lyophilization USA Conference arranged to take place on the 23rd and 24th October 2019\, in Boston. \n \nThe current list of FDA-approved biopharmaceuticals contains up to 50% of injectables and approximately a third of all parenterals being lyophilized\, which suggests it is the optimal way of ensuring stability in products that are unstable in aqueous solution. This instability or degradation can result in suboptimal product performance and even toxicity in worst cases indicating the need for lyophilization despite it’s inherently expensive running costs and time-consuming process. \nJoin us this year to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of lyophilization. Benchmark and network with industry leaders and discuss the most up to date and relevant topics that delve into alternative lyophilization approaches\, applied statistical modelling\, fresh views on scaling up and tech transfer\, pre- and post-product characterization. regulation and beyond. \nDISCUSSION HIGHLIGHTS: \nGain valuable insight into the most current challenges and considerations when working with highly concentrated and sensitive formulations \nExplore new and innovative approaches in model-based studies that utilise the power of statistical analysis to improve process development and understanding \nDiscuss the future outlook of lyophilization through trends in alternative approaches \nDiscover updates on the leading PAT technologies such as controlled nucleation\, continuous freeze drying\, low-frequency Raman\, vacuum-foam drying and more. \nListen to key opinion leaders and experts from regulatory bodies speak about expectations and the assessment of reliable technologies in the market \nView the full agenda: www.lyophilisation-usa.com/PJBan \nContact Info:\nT: +44 (0) 20 7827 6164\nE: nhoward@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/lyophilization-usa-2019/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
ORGANIZER;CN="SMi Group Ltd":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191026
DTSTAMP:20260515T010858
CREATED:20180725T131813Z
LAST-MODIFIED:20190717T090554Z
UID:16872-1571788800-1572047999@www.pharmajournalist.com
SUMMARY:3rd Annual NASH Summit Europe 2019
DESCRIPTION:Welcome to Europe’s Gathering of NASH Drug Developers: The 3rd NASH Summit Europe\n\nDeepen Understanding of the Role of Liver Fibrosis in NASH\nConfidently Meet Regulatory Guidelines\nDefine Clinical Trial Endpoints\n\n \nReturning as the only NASH forum exclusively facilitating industry-to-industry dialogue and collaboration in Europe; the 3rd NASH Summit Europe will once again showcase leading data and leverage expert insights to advance pipeline success in NASH. \n“The NASH Summit was unlike any scientific meeting I have ever been to.  Everyone who attended was interested in some aspect of drug development for NASH.  I truly enjoyed the “applied science” focus of the meeting as it helped me where I most needed the help.  The opportunity to network and learn informally in the poster session and during receptions was excellent.”\nEli Lilly \nSee & hear from the 3rd NASH Summit Boston attendees to better understand how the NASH Summit is uniquely dedicated to advancing the therapeutic potential of NASH therapeutic \nTo learn more about this event\, and to register online\, visit https://nash-europe.com/ \nContact:\nPhone – +44 (0)20 3141 8700\nEmail – info@hansonwade.com
URL:https://www.pharmajournalist.com/event/nash-summit-europe/
LOCATION:The Waldorf Hilton\, London\, Aldwych\, London\, WC2B 4DD\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191026
DTSTAMP:20260515T010858
CREATED:20190712T103804Z
LAST-MODIFIED:20190712T104710Z
UID:21568-1571788800-1572047999@www.pharmajournalist.com
SUMMARY:Neuromuscular Drug Development Summit (NMD)
DESCRIPTION:Now in its 2nd year\, the industry-focused NMD Summit will overcome the challenges preventing neuromuscular drug developers bringing truly transformative therapeutics to market. \nWith an emphasis on ALS\, SMA\, DMD and other rare diseases\, 18 expert speakers from the likes of Biogen\, Audentes and PTC Therapeutics will share their insights across 3 packed days. \nJoin 90+ neuromuscular stakeholders at this definitive forum to exchange novel ideas\, gather lessons learned and establish new collaborations. \nTo learn more about this event\, and to register online\, visit https://ter.li/bgvvh7
URL:https://www.pharmajournalist.com/event/neuromuscular-drug-development-summit-nmd/
LOCATION:The Westin Boston Waterfront\, 425 Summer Street\, Boston\, Massachusetts\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191026
DTSTAMP:20260515T010858
CREATED:20190827T091030Z
LAST-MODIFIED:20190827T091030Z
UID:22138-1571788800-1572047999@www.pharmajournalist.com
SUMMARY:BioNetwork 2019
DESCRIPTION:BioNetwork\nOctober 23 – 25\, 2019\nThe Ritz-Carlton Laguna Niguel\, CA \nFor the past 15 years\, BioNetwork has brought together the most senior-level decision makers in pharma and biotech deal-making (CEOs of BioTechs\, VPs of BD from Big Pharma). Meet the right people and create the ideal partnerships. \n \nDiscount Code: BN19PJ \nTo learn more about BioNetwork 2019 and to register online\, visit http://bit.ly/2ZnZSRN
URL:https://www.pharmajournalist.com/event/bionetwork-2019/
LOCATION:The Ritz-Carlton Laguna Niguel\, CA
ORGANIZER;CN="Worldwide Business Research":MAILTO:Cynthia.Liu@wbresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191024
DTEND;VALUE=DATE:20191026
DTSTAMP:20260515T010858
CREATED:20190612T113524Z
LAST-MODIFIED:20190612T113524Z
UID:21136-1571875200-1572047999@www.pharmajournalist.com
SUMMARY:2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress
DESCRIPTION:MarketsandMarkets is proud to announce the 2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress to be held on 24th-25th October 2019 in Boston\, USA. With the increasing recognition of real-world data opportunities and challenges within the pharmaceutical and biotech industry\, life sciences organizations face clear decisions on how specifically to put resources into real-world evidence capacities. \nReal-World Evidence can possibly change the way life sciences associations use advancements to increase further clinical bits of knowledge and enable them and payers to collaborate like never before. After the successful inaugural\, the 2nd Annual Real-World Data and Life Science Analytics Congress will hold discussions on accelerating the adoption of Real-world evidence within the industry while understanding the capabilities of newer technologies for evidence generation. The congress will also address upcoming changes in the regulatory landscape with the recent framework by the FDA. \nOur aim for the 2nd Annual Real-World Data and Life Science Analytics Congress is to unite all stakeholders to see how to use conventional informational indexes and layer that in with innovative analytical techniques and new working models.
URL:https://www.pharmajournalist.com/event/2nd-annual-marketsandmarkets-real-world-data-and-life-science-analytics-congress/
LOCATION:Boston\, USA
ORGANIZER;CN="MarketsandMarkets Research Private Ltd.":MAILTO:Shardul.oza@marketsandmarkets.com
END:VEVENT
END:VCALENDAR